| - GRCh37:
- Chr22:40816458
- GRCh38:
- Chr22:40420454
| MRTFA | S335L, S370L, S385L, S435L | Immunodeficiency 66, not provided | Uncertain significance (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:40815085
- GRCh38:
- Chr22:40419081
| MRTFA | V453M, V488M, V503M, V553M | Immunodeficiency 66, not provided | Uncertain significance (Jul 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:40814835
- GRCh38:
- Chr22:40418831
| MRTFA | A536V, A571V, A586V, A636V | not provided, Immunodeficiency 66 | Uncertain significance (Mar 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:40814826
- GRCh38:
- Chr22:40418822
| MRTFA | R539H, R574H, R589H, R639H | not provided, Immunodeficiency 66 | Uncertain significance (Aug 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:40814719
- GRCh38:
- Chr22:40418715
| MRTFA | V575M, V610M, V625M, V675M | Immunodeficiency 66, not provided | Uncertain significance (Oct 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:40814462
- GRCh38:
- Chr22:40418458
| MRTFA | | Immunodeficiency 66, not provided | Conflicting interpretations of pathogenicity (Aug 6, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:40807562
- GRCh38:
- Chr22:40411558
| MRTFA | M876I, M911I, M926I, M976I | not provided, Immunodeficiency 66 | Uncertain significance (Oct 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:40814497
- GRCh38:
- Chr22:40418493
| MRTFA | L649I, L684I, L699I, L749I | Immunodeficiency 66, not provided | Benign/Likely benign (Oct 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:40813065
- GRCh38:
- Chr22:40417061
| MRTFA | | not provided, Immunodeficiency 66 | Benign/Likely benign (Oct 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:40813395
- GRCh38:
- Chr22:40417391
| MRTFA | K723*, K758*, K773*, K823* | Immunodeficiency 66 | Pathogenic (Apr 17, 2020) | no assertion criteria provided |